pruritus
Advertisement
Researchers sought to quantify the population at risk for pruritus, clinical determinants, and associated adverse outcomes.
Research examined the role of serum phosphate in CKD-associated pruritus and the efficacy of treatment with difelikefalin.
Patients with end-stage renal disease (ESRD) commonly experience multiple comorbidities, including fatigue, muscle ...
Patients with end-stage kidney disease undergoing dialysis frequently develop uremic pruritus. There are direct ...
Patients with advanced chronic kidney disease (CKD) commonly experience pruritus. Pruritus is associated with ...
Patients with advanced chronic kidney disease (CKD) commonly experience pruritus. Pruritus is associated with ...
Pruritus is an extremely uncomfortable condition with negative impacts on patient quality of life. Patients with chronic ...
The approval by the US FDA on August 23, 2021, of difelikefalin (marketed as Korsuva™ by Cara Therapeutics) is a major ...
ANNA 2021 National Symposium
...
Washington, DC—More than 40% of patients with chronic kidney disease (CKD) undergoing hemodialysis have ...
Advertisement
630 Madison Ave.
Manalapan, NJ 07726
© 2025 Mashup Media, LLC, a Formedics Property. All Rights Reserved.